CAPN13
Calpain-13
Also known as: CAN13_HUMAN, FLJ23523
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6MZZ7
- Gene
- CAPN13
- Ensembl
- ENSG00000162949
- Chromosome
- 2
- Canonical length
- 669 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes a member of the calpain large subunit family. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
669 residues, UniProt reviewed canonical sequence.
>Q6MZZ7|CAPN13
1 MAYYQEPSVE TSIIKFKDQD FTTLRDHCLS MGRTFKDETF PAADSSIGQK LLQEKRLSNV
61 IWKRPQDLPG GPPHFILDDI SRFDIQQGGA ADCWFLAALG SLTQNPQYRQ KILMVQSFSH
121 QYAGIFRFRF WQCGQWVEVV IDDRLPVQGD KCLFVRPRHQ NQEFWPCLLE KAYAKLLGSY
181 SDLHYGFLED ALVDLTGGVI TNIHLHSSPV DLVKAVKTAT KAGSLITCAT PSGPTDTAQA
241 MENGLVSLHA YTVTGAEQIQ YRRGWEEIIS LWNPWGWGEA EWRGRWSDGS QEWEETCDPR
301 KSQLHKKRED GEFWMSCQDF QQKFIAMFIC SEIPITLDHG NTLHEGWSQI MFRKQVILGN
361 TAGGPRNDAQ FNFSVQEPME GTNVVVCVTV AVTPSNLKAE DAKFPLDFQV ILAGSQRFRE
421 KFPPVFFSSF RNTVQSSNNK FRRNFTMTYH LSPGNYVVVA QTRRKSAEFL LRIFLKMPDS
481 DRHLSSHFNL RMKGSPSEHG SQQSIFNRYA QQRLDIDATQ LQGLLNQELL TGPPGDMFSL
541 DECRSLVALM ELKVNGRLDQ EEFARLWKRL VHYQHVFQKV QTSPGVLLSS DLWKAIENTD
601 FLRGIFISRE LLHLVTLRYS DSVGRVSFPS LVCFLMRLEA MAKTFRNLSK DGKGLYLTEM
661 EWMSLVMYNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAPN13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 28 nTPM
- stomach: 27 nTPM
- rectum: 23 nTPM
- duodenum: 20 nTPM
- colon: 11 nTPM
- cervix: 9.1 nTPM
Single-cell type
- conjunctival goblet cells: 783 nCPM
- enterocytes: 161 nCPM
- respiratory secretory cells: 120 nCPM
- foveolar cells: 112 nCPM
- prostatic hillock cells: 106 nCPM
- prostatic club cells: 94 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 4.5 nTPM
- cerebral cortex: 2.8 nTPM
- basal ganglia: 2.5 nTPM
- midbrain: 2.2 nTPM
- medulla oblongata: 2 nTPM
- thalamus: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CAPN13.
Disease | ImmuneIEDB
Conditions an epitope on CAPN13 was assayed in.
- invasive ductal carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.09
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase C2, calpain, catalytic domain
- EF-hand domain pair
- Peptidase C2, calpain, large subunit, domain III
- Peptidase C2, calpain family
- Calpain large subunit, domain III superfamily
- Papain-like cysteine peptidase superfamily
- Calpain-3/13-like, C-terminal EF-hand
- Calpain family cysteine protease
- Calpain large subunit, domain III
- Calpain-13-like, C-terminal EF-hand
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAPN13 as an antibody target. Whether an autoantibody or antibody against CAPN13 could matter depends on whether native CAPN13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAPN13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAPN13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...